Efficacy and safety of intravenous fosfomycin for the treatment of difficult-to-treat Gram-negative bacterial infections

• Prif Awduron: Tasneem A.K. Abdallah (Awdur), Reem Elajez (Awdur), Tawheeda B. Ibrahim (Awdur), Abeir B. Alimam (Awdur), Ali S. Omrani (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Elsevier, 2021-11-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

We reviewed the efficacy and safety of intravenous (IV) fosfomycin for the treatment of infections caused by Gram-negative bacteria (GNB) with difficult-to-treat resistance (DTR). Data were retrospectively retrieved for all hospitalized patients who received IV fosfomycin for ≥48 h for the treatment...